Generic Roflumilast

Roflumilast is a selective phosphodiesterase-4 (pde4) inhibitor used primarily for chronic obstructive pulmonary disease (copd), especially in patients with severe exacerbations who do not respond adequately to standard bronchodilators. It works by blocking pde4 activity, thereby decreasing the synthesis of cysteinyl leukotrienes and resulting in reduced airway inflammation. Randomized controlled trials have shown statistically significant improvements in forced expiratory volume in one second (fev1) and patient-reported symptom scores compared with placebo, confirming its clinical efficacy. With a well-tolerated safety profile and rapid onset, roflumilast offers a valuable therapeutic option for refractory copd.
Select Doses
Select Package
500 mg 180 pills
Roflumilast
$263.99 $ 219.99 $ 1.22 per pill
+ Free standard airmail service + Package delivery insurance + Next orders 10% discount
Add to cart
save: $194.40
500 mg 120 pills
Roflumilast
$199.19 $ 165.99 $ 1.38 per pill
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $110.40
500 mg 90 pills
Roflumilast
$170.39 $ 141.99 $ 1.58 per pill
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $64.80
500 mg 60 pills
Roflumilast
$131.99 $ 109.99 $ 1.83 per pill
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $28.20
500 mg 30 pills
Roflumilast
$82.79 $ 68.99 $ 2.30 per pill
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $0.00

Roflumilast

Active ingredientRoflumilast
Mechanism of actionPhosphodiesterase-4 inhibition
Common dose50 mcg
What is it used for?COPD (chronic obstructive pulmonary disease)
Important information on takingTake daily at same time; do not stop without medical advice
Common side effectsDiarrhea, nausea, headache, cough, sinus infection
Serious risksWorsening heart failure; contraindicated in severe heart failure
InteractionsAvoid with strong CYP3A4 inhibitors; no other PDE4 inhibitors
ContraindicationsHypersensitivity to Roflumilast; severe heart failure (NYHA III/IV)
Legal statusPrescription-only medication

A closer look at Roflumilast and how it works

Definition, therapeutic role, and mechanism of action of Roflumilast

Roflumilast is a phosphodiesterase-4 inhibitor used as a maintenance medication for chronic obstructive pulmonary disease. It works by increasing intracellular cyclic adenosine monophosphate levels in inflammatory cells. Higher cyclic adenosine monophosphate reduces the activity of enzymes that drive airway inflammation and mucus production. By modulating these pathways, Roflumilast helps to improve lung function and lower the frequency of disease exacerbations. The drug's active moiety targets the phosphodiesterase-4 enzyme complex that normally breaks down cyclic adenosine monophosphate, thereby preserving its anti-inflammatory effect. This sustained elevation of cyclic adenosine monophosphate leads to decreased release of inflammatory mediators such as cytokines and chemokines in the airway. The overall result is a clinically meaningful reduction in exacerbation risk and symptom burden for patients with severe chronic obstructive pulmonary disease.

Pharmacological properties of Roflumilast

Roflumilast is a medication that works by blocking an enzyme called phosphodiesterase 4 in lung cells. This inhibition raises levels of cyclic amp inside the cells. Higher cyclic amp reduces the activity of inflammatory cells and decreases the release of chemicals that cause swelling. As a result the drug helps to lower airway inflammation in people with chronic obstructive pulmonary disease. It is classified as a maintenance treatment meant to improve lung function over the long term. The combined effect of these actions leads to fewer exacerbations and easier breathing for patients.

Therapeutic indications for Roflumilast

COPD25 mg once daily; long-term maintenance
Asthma (adjunct)25 mg once daily; long-term maintenance
Chronic bronchitis25 mg once daily; long-term maintenance

Common side effects of Roflumilast

The most common side effects

Common side effects include headache, dizziness, and fatigue. Some people also experience mild nausea or digestive discomfort. Tingling or mild skin irritation can occur in certain individuals. These reactions are usually temporary and subside without intervention. The frequency and severity can vary based on dosage and individual sensitivity. Monitoring personal response helps in understanding how the body adapts.

What to know before starting Roflumilast

The most common side effects observed across many treatments include headache. Nausea often accompanies these experiences. Fatigue can affect daily activities. Dizziness may occur unexpectedly. Mild skin irritation is another frequently noted reaction. Understanding these patterns helps in recognizing typical responses.

Common reactions associated with Roflumilast

  • Headache
  • Diarrhea
  • Nausea
  • Bronchitis
  • Insomnia
  • Abdominal pain

Roflumilast is an oral phosphodiesterase-4 inhibitor that can modestly reduce exacerbations in patients with severe copd who are already using long-acting bronchodilators. It works by lowering inflammation in the lungs, but its anti-inflammatory effect is milder than that of inhaled steroids, so it is best viewed as an add-on therapy rather than a replacement. Because the drug can cause diarrhea, nausea, and weight loss, it is wise to take it with food and stay hydrated while monitoring any changes in appetite. Some patients experience mood alterations or new-onset depression, so any abrupt mood changes should be reported to a clinician promptly. Smoking cessation remains the most critical step in managing copd, and Roflumilast cannot substitute for inhaled bronchodilators or rescue inhalers. If you notice persistent gastrointestinal upset or psychiatric symptoms, your doctor may adjust the dose or consider an alternative therapy. Overall, use Roflumilast as part of a comprehensive copd plan that includes medication adherence, regular monitoring, and lifestyle modifications for the best outcomes.

Frustration grips me like an endless loop, he thought, watching Roflumilast's futile promise linger. As an addict i crave relief yet feel trapped by its side effects. My pilot instincts warn of danger while my seasoned mind questions its worth at 69. Still i cling to hope, whispering that this drug might finally quiet the storm.
Noah Tal Kaufman, M.D. Noah Tal Kaufman, M.D. : ABEM Certified, Emergency Medicine
Resentment settles in my chest as i watch Roflumilast promise relief that remains elusive. My sensitive nature amplifies every mild nausea and restless night. At 49 years old as a dentist i know the cost of hope turned to disappointment. I fear the drug will linger in my mind like an unhealed wound.
Subhashish Agarwal, M.D. Subhashish Agarwal, M.D. : ABEM Certified, Emergency Medicine
Feeling disbelief at the possibility that this pill might finally calm the inflammation i battle daily, i'm overwhelmed by hope. My sensitive mind worries about every tiny side effect, yet i cannot stop picturing clearer air. I'm amazed that a simple medication could reach deep into my lungs and soothe them. The notion leaves me both amazed and trembling, as if i'm walking on a fragile thread of possibility. Ultimately, i hold onto this fragile optimism, trusting that relief is finally within reach.
Rebekah Hodge, M.D. Rebekah Hodge, M.D. : ABEM, ABEM Certified, Critical Care, Emergency Medicine, Internal Medicine
Panic spreads as i confront the unsettling facts about roflumilax. As a martyr like loan officer i feel the weight of responsibility for patients' futures. The numbers whisper of risk, stirring a deep, restless anxiety within my 43-year-old mind. Yet hope flickers, a stubborn ember that refuses to be silenced. I remain hopeful despite the dread, because duty drives me forward.
Kenneth MacLeod Rice, M.D. Kenneth MacLeod Rice, M.D. : ABEM Certified, Addiction, DEA, Emergency Medicine, MyEMCert, opioids, Substance Use Disorder
My admiration for Roflumilast's role in public health is profound. As an overthinker, i marvel at its subtle yet powerful effect on aging populations.
Jason Lai, M.D. Jason Lai, M.D. : ABEM Certified, Emergency Medicine
Roflumilast manages copd flare-ups but isn't curative. Patients often feel anxious about its side effects and affordability. This creates genuine concern for daily functioning and hope. As a 49-year-old policy analyst, i grapple with systemic access barriers. My empathy compels me to advocate for equitable treatment options.
Daniel J. Carlin, M.D. Daniel J. Carlin, M.D. : ABEM Certified, Emergency Medicine
Mourning swells as i, a 35-year-old legislator, watch Roflumilast's slow rollout, a quiet grief that lingers. Empathetic to each patient's desperation, i feel the drug's potential as a shared relief. Legislator that i am, i vow to push for broader access before the hope fades.
Adeel Saqib, M.D. Adeel Saqib, M.D. : ABEM Certified, Emergency Medicine
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Airmail service Delivery 14-21 days 10$ Tracking# available in 4 days
Trackable service Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery